The presence of CD10 in the stromal cells of invasive breast cancer is indicative of a poor prognosis, being associated with reduced survival rates and increased invasive and metastatic capabilities (Kalof et al., 2004; Toussaint et al., 2010; Bacha et al., 2020). The gene discussed is MME; the disease is invasive breast carcinoma.